This study focuses on a possible role of intercellular adhesion molecule-1
(ICAM-1) in interstitial pulmonary diseases. We determined a soluble form o
f ICAM-1 in serum and bronchoalveolar lavage fluid (BALF) using ELISA in pa
tients with usual interstitial pneumonia (UIP), bronchiolitis obliterance o
rganizing pneumonia (BOOP), or nonspecific interstitial pneumonia (NSIP). I
n addition, we investigated the expression of ICAM-1 in the lung tissues of
these patients by means of immunohistochemical staining. Serum levels of s
oluble ICAM-1 were significantly higher in patients with UIP or NSIP than i
n healthy subjects, and were also high in patients with BOOP. The soluble I
CAM-1 in BALF tended to be higher in patients with UIP, BOOP, or NSIP than
in normal subjects. A significant correlation was seen between soluble leve
ls of ICAM-1 in serum and BALF. In the immunostaining of ICAM-1 of the lung
tissues, ICAM-1 expression was more pronounced in patients with UIP than i
n those with BOOP or NSIP. The increased expression of ICAM-1 was seen in t
ype II alveolar epithelium and vascular endothelium in patients with inters
titial pneumonia. A positive correlation was observed between the degree of
ICAM-1 expression in the lung tissues and the BALF levels of soluble ICAM-
1. The expression of ICAM-1 in type II alveolar epithelium suggests that IC
AM-1 plays a specific role in the fibrotic process of the lung, and that th
e measurement of soluble ICAM-1 in sera and BALF could be a useful marker f
or evaluating the progression of fibrosis.